Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Euthyroidism and Long-Term Remission of Graves' Hyperthyroidism Following Treatment With an FcRn Blocker: A Case Report.

Thyroid : official journal of the American Thyroid Association·2026

Same author

Lost to follow-up while undergoing intravitreal injection therapy: barriers to adherence in a real-world setting.

International journal of retina and vitreous·2026

Same author

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

The Journal of clinical endocrinology and metabolism·2025

Same author

Type 1 Diabetes and Other Autoimmune Diseases-Epidemiology, Pathophysiology and Screening.

Endocrinology, diabetes & metabolism·2025

Same author

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy.

European thyroid journal·2025

Same author

Functional vision in daily life: Clinical and patient-reported outcomes 18 months after enhanced partial range of field IOL implantation.

PloS one·2025

Search research articles

Related Experiment Video

Updated: May 19, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Autoimmune thyrotoxicosis: diagnostic challenges.

Katharina A Ponto¹, George J Kahaly

¹Gutenberg University Medical Center, Department of Ophthalmology, Mainz, Germany.

The American Journal of Medicine

|September 4, 2012

Summary

This summary is machine-generated.

Graves' disease (GD) is a common autoimmune cause of hyperthyroidism, particularly in women. Genetic factors and specific autoantibodies targeting the thyroid stimulating hormone receptor (TSHR) are key to its development and diagnosis.

More Related Videos

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Area of Science:

Endocrinology
Immunology
Genetics

Background:

Graves' disease (GD) is the predominant cause of hyperthyroidism in the United States, affecting 1-2% of the population, with a 5:1 female predominance.
Susceptibility to GD is linked to genetic factors, evidenced by familial clustering, high sibling recurrence rates, and the presence of thyroid autoantibodies within families.
GD is a systemic autoimmune disorder involving immune cell infiltration of the thyroid and TSHR-expressing tissues, leading to autoantibody production.

Discussion:

Stimulatory autoantibodies in GD activate the TSHR, causing thyroid hyperplasia and excessive thyroid hormone production.
Diagnosis is facilitated by characteristic clinical findings such as a diffusely enlarged, hypervascular thyroid gland, associated orbitopathy, confirmed thyrotoxicosis, and positive TSHR autoantibodies.
A family history of autoimmune disorders is frequently observed in patients with Graves' disease.

Key Insights:

The pathogenesis of Graves' disease involves immune system dysregulation targeting the thyroid stimulating hormone receptor.
Diagnostic criteria for GD integrate clinical presentation, biochemical data, immunological markers (TSHR autoantibodies), and imaging findings.
Genetic predisposition plays a significant role in the susceptibility and familial aggregation of Graves' disease.

Outlook:

Further research into the genetic underpinnings of GD may reveal novel therapeutic targets.
Understanding the mechanisms of TSHR activation by autoantibodies can inform the development of targeted treatments for Graves' disease.
Investigating the interplay between genetic susceptibility and environmental factors could provide a more comprehensive view of GD etiology.